FDA lifts clinical hold on Amylyx’s Phase I ALS trial
The US Food and Drug Administration (FDA) has lifted a clinical hold on Amylyx Pharmaceuticals’ Phase I trial of AMX0114 …
Post
-
-
PFAS in drinking water linked with increased incidence of cancer in the US
Synthetic chemicals called per- and polyfluoroalkyl substances (PFAS) have been accumulating in the environment since their introduction in the 1940s, …
-
Key Lead Generation Providers and Technology Solutions for the Clinical Trials Industry
Leading lead generation providers and technology solutions for the clinical trials industry: Introduction The clinical trials sector is a critical component …
-
Pulse Biosciences touts positive results from PFA early feasibility study
Pulse Biosciences has reported positive results from a first-in-human feasibility study evaluating its nanosecond pulsed field ablation (nsPFA) technology for …
-
Ascletis Pharma’s ASC30 oral tablet shows promise in obesity trial
Ascletis Pharma has reported positive topline outcomes from its US Phase Ia single ascending dose (SAD) study of the oral …
-
Leading Sales Enablement, Prospecting and Automation Providers and Technology Solutions for the Clinical Trials Industry
Leading sales enablement, prospecting and automation providers and technology solutions for the clinical trials industry: Introduction In the rapidly evolving landscape …
-
CEPI provides $6.2m to push first mRNA-based Rift Valley fever vaccine into trial
South African biotech Afrigen Biologics has secured a $6.2m grant from the Coalition for Epidemic Preparedness Innovations (CEPI) to develop …
-
Streamlining mesenchymal stem cell (MSC) expansion
As cell and gene therapies become more prevalent, the need for streamlined, GMP-compliant MSC production continues to grow. Laboratories must …
-
Trump signs executive order to leave World Health Organization
President Donald Trump has signed an executive order for the US to leave the World Health Organization (WHO). As one of …
-
Valneva announces positive outcomes from chikungunya vaccine trial
Valneva has announced positive outcomes from its Phase III VLA1553-321 trial of the single-shot IXCHIQ chikungunya virus (CHIKV) vaccine in …
-
YolTech Therapeutics to commence trial of TDT therapy
YolTech Therapeutics is set to commence a trial of its in vivo gene editing therapy, YOLT-204, aimed at treating transfusion-dependent …
-
Clinical Trials Arena Excellence Awards 2024 – Winners Announced!
The Clinical Trials Arena Excellence Awards Winners have been announced! To see the full list you can download the full …
-
SK bioscience and Sanofi’s GBP410 vaccine enters global Phase III trials
SK bioscience and Sanofi have announced plans for global Phase III studies, which will assess the safety and immunogenicity of …
-
High coffee intake linked to decreased head and neck cancer risk
According to data derived from the World Health Organization’s Global Cancer Observatory, head and neck cancer (HNC) is the seventh …
-
Report finds 70% spike in advanced therapy Phase I trials in UK
Last year saw a 70% rise in Phase I advanced therapy medicinal product (ATMP) studies across the UK clinical trials …
